POR On-Target Side Effects of Targeted Therapeutics of Cancer

The concept of precision medicine is based on the identification of hallmarks of cancer to exploit them as drug targets. The basic idea was that in this way the therapeutic modalities will be more effective and the side effects will be less. Since the majority of these novel modalities are not specific for a cancer-related biological process or a cancer-specific (mutant) target protein, it is not a surprise that we had to learn new type of side effects, because these therapeutics also affect physiological or pathological processes. Even more, in cases of some of these novel therapies we were able to discover new molecular mechanisms of physiological and pathological processes. Identification of the on-target side effects of targeted drugs can help to prevent the development of them or better manage the patients when emerge during cancer therapy.

Photo-Activated Ferroptosis for Cancer Therapy: Advances, Challenges, and Prospects

Regulated cell death (RCD) in cancer: key pathways and targeted therapies

Advances in ovarian cancer therapy Cancer Chemotherapy and Pharmacology

Targeted therapy and immunotherapy in the cancer-immunity cycle. The

Targeted therapy - Wikipedia

Targeted therapy for hormone receptor-positive breast cancer

Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine - ScienceDirect

Frontiers Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment

Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy - ScienceDirect

Intratumoural administration and tumour tissue targeting of cancer immunotherapies

POR On-Target Side Effects of Targeted Therapeutics of Cancer